These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32134226)

  • 1. [Aspirin for primary cardiovascular prevention : the end of an era ?].
    Ravach G; Fournier S; Mazzolai L; Nanchen D
    Rev Med Suisse; 2020 Mar; 16(684):459-462. PubMed ID: 32134226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of aspirin as antiaggregant therapy in primary prevention. An update.
    Jiménez-García N; de la Torre Lima J; García Alegría J
    Med Clin (Barc); 2019 Oct; 153(8):326-331. PubMed ID: 31521369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin use for primary prevention in elderly patients.
    Terrosu P
    Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):728. PubMed ID: 27374042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.
    Volpe M; Battistoni A; Gallo G; Coluccia R; De Caterina R
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):331-339. PubMed ID: 28573479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for primary prevention: what's a clinician to do?
    Psotka MA; Fleischmann KE
    J Gen Intern Med; 2015 Feb; 30(2):147-9. PubMed ID: 25451988
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin for primary prevention of cardiovascular disease: is it time to move on?
    Knickelbine T; Miedema MD
    Curr Opin Cardiol; 2019 Sep; 34(5):510-513. PubMed ID: 31219876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
    Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
    High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
    Mora S; Manson JE
    JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for the primary prevention of cardiovascular disease: latest evidence.
    Capodanno D; Ingala S; Calderone D; Angiolillo DJ
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):633-643. PubMed ID: 31382819
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
    Matthys F; De Backer T; De Backer G; Stichele RV
    Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for primary prevention: Is this the end of the road?
    Singal AK; Karthikeyan G
    Indian Heart J; 2019; 71(2):113-117. PubMed ID: 31280821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PACE pilot study: 12-month results and implications for future primary prevention trials in the elderly. (Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly).
    Silagy CA; McNeil JJ; Donnan GA; Tonkin AM; Worsam B; Campion K
    J Am Geriatr Soc; 1994 Jun; 42(6):643-7. PubMed ID: 8201151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence.
    Dasa O; Pepine CJ; Pearson TA
    Am J Cardiol; 2021 Feb; 141():38-48. PubMed ID: 33221264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for primary prevention of stroke in individuals without cardiovascular disease-A meta-analysis.
    Judge C; Ruttledge S; Murphy R; Loughlin E; Gorey S; Costello M; Nolan A; Ferguson J; Halloran MO; O'Canavan M; O'Donnell MJ
    Int J Stroke; 2020 Jan; 15(1):9-17. PubMed ID: 31237833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
    Godley RW; Hernandez-Vila E
    Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
    [No Abstract]   [Full Text] [Related]  

  • 17. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
    Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
    G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Aspirin for Primary Prevention in Persons with Diabetes Mellitus and in the Elderly.
    Patel NJ; Baliga RR
    Curr Cardiol Rep; 2020 May; 22(7):48. PubMed ID: 32472363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have we learned about using aspirin for primary prevention from the ASCEND and ARRIVE trials?
    Tousoulis D
    Cardiovasc Res; 2019 Feb; 115(2):e15-e16. PubMed ID: 30668678
    [No Abstract]   [Full Text] [Related]  

  • 20. A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
    Wu IC; Hsieh HM; Yu FJ; Wu MC; Wu TS; Wu MT
    Eur J Clin Invest; 2016 Feb; 46(2):130-40. PubMed ID: 26640116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.